Indivior Share Discussion Threads

[waldron] 16/2/2023 08:39

Could it be to do with a competitors product being accepted by FDA

WILL LOOK BUT MUST GO OUT FOR A WHILE

[thebeast1] 16/2/2023 08:32

No idea why the massive drop in share price here. Didn't see anything negative that was new

[blondviking] 16/2/2023 08:18

Wow, for a change Stop loses worked well and I was out at 8.02am on all positions

[dealy] 16/2/2023 08:12

I lost track of the litigation here so please forgive me. Is this an increase in the total amount they have to pay? Have they already paid some of the penalty? I see they have 990m cash - is this net cash?

[youngers] 16/2/2023 08:08

Underlying results were spot on. Shame about another provision but reaction seems over done

[dealy] 16/2/2023 08:07

what's happening here?

[waldron] 14/2/2023 07:35

AYE CASH

adrian j boris
2 Feb '23 - 09:04 - 3580 of 3585
0 4 0
Upcoming events on INDIVIOR PLC


Feb/16/2023 | 07:00am FY 2022 Earnings Release

Feb/16/2023 | 01:00pm FY 2022 Earnings Call

[casholaa] 13/2/2023 22:37

FY Thursday 16 Feb.

[casholaa] 08/2/2023 12:40

Ahhhh i need to put eyes on, you're totally correct.

[youngers] 08/2/2023 12:27

No thanks to $20 per share when we are at over £19 cheers

[casholaa] 08/2/2023 12:10

Pleased with that, but I would have preferred Op to have given us $20 a share hehehehe

[adrian j boris] 08/2/2023 07:24

(MT Newswires) -- Indivior (INDV.L) received the Committee on Foreign Investment in the US approval to acquire Nasdaq-listed Opiant Pharmaceuticals, according to a Tuesday release.

The clearance comes after the committee found that the proposed deal poses no unresolved national security concerns. The UK Competition and Markets Authority also decided to take no further action.

In November 2022, Indivior agreed to make an upfront cash payment of $20 per share, or a total of $145 million, plus up to $8 per share in contingent value rights, subject to the achievement of certain net revenue milestones in the seven years after the launch and approval of OPNT003, or nasal nalmefene.

The US pharmaceutical company's board unanimously recommended that shareholders vote in favor of the merger at a meeting on March 1.

Indivior's London shares fell marginally at the close of trading on Tuesday.

[adrian j boris] 02/2/2023 09:04

Upcoming events on INDIVIOR PLC


Feb/16/2023 | 07:00am FY 2022 Earnings Release

Feb/16/2023 | 01:00pm FY 2022 Earnings Call

[steeplejack] 02/2/2023 07:56

Umm....as soon as attention was drawn to share outperformance,down went the price!Inevitable i guess.My view has always been that a quiet bulletin board is a 'healthy' board which defeats the purpose of having a board at all i suppose.When boards start attracting a lot of comment,you usually surmise that things aren't going that smoothly.As an example,look at Oxford Biomedica BB.Down around 75% from its all time high 18 months back,the BB attracts more posts than probably any other site on ADVFN.Its competing with the Lancet and New England Medical Journal.£20 would appear to be a bit of a hurdle but hopefully upcoming ADR listing will nurture interest that will see the price kick on.

[villarich] 24/1/2023 11:04

Ha I was thinking the same thing yesterday. This is by far and away my best performing share over the last 3 years

[casholaa] 24/1/2023 00:00

This should be how all our investments should look. I'm minded to print it out and frame it.

[villarich] 23/1/2023 23:16

The 3 year chart is a thing of beauty.

[youngers] 15/1/2023 10:46

PE for 2022 won’t be anywhere near that level due to fantastic growth being delivered and expected to continue. EPS through 3 quarters is already 75p so PE will be more like 19x

Stick another 80% growth for 2023 on top line and the forward PE falls through the floor

Nasdaq listing to come imminently too is seeing institutional investors get on board in advance of that

GLA … DYOR

[arja] 15/1/2023 10:37

great looking chart in nice steady uptrend with next resistance at about 2100 level . BUT not sure why with a p/e of about 89 and high gearing and maybe someone who studies the fundamentals can explain it ? However , as a chartist I mainly trade on what chart tells me but like a company to have good fundamentals .

[youngers] 30/12/2022 09:01

Looking set for a great finish to 2022 here. Massive growth being delivered and US listing to look forward to in 2023. GLA

[youngers] 08/12/2022 16:58

Closing price distorted again by rogue trade

[gregmorg] 07/12/2022 18:32

Yes I think you are right. Though forgive me, Once is enough though!

[baddeal] 07/12/2022 17:22

If fell into the 30's I think

[steeplejack] 07/12/2022 13:35

And what goes around comes around Greg......the first shall be last and the last shall be first!This has been a splendid recovery over the last couple of years.The shares are 350 odd in old money and i think the stock fell as low as 50p at one point.